Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

The effects of needle-sharing and opioid substitution therapy on incidence of hepatitis C virus infection and reinfection in people who inject drugs.

Aitken CK, Agius PA, Higgs PG, Stoové MA, Bowden DS, Dietze PM.

Epidemiol Infect. 2017 Mar;145(4):796-801. doi: 10.1017/S0950268816002892. Epub 2016 Dec 8.

PMID:
27927256
2.
3.

The relationships between IFNL4 genotype, intrahepatic interferon-stimulated gene expression and interferon treatment response differs in HCV-1 compared with HCV-3.

Holmes JA, Congiu M, Bonanzinga S, Sandhu MK, Kia YH, Bell SJ, Nguyen T, Iser DM, Visvanathan K, Sievert W, Bowden DS, Desmond PV, Thompson AJ.

Aliment Pharmacol Ther. 2015 Aug;42(3):296-306. doi: 10.1111/apt.13263. Epub 2015 Jun 1.

4.

Analysis of Post-Liver Transplant Hepatitis C Virus Recurrence Using Serial Cluster of Differentiation Antibody Microarrays.

Rahman W, Tu T, Budzinska M, Huang P, Belov L, Chrisp JS, Christopherson RI, Warner FJ, Bowden DS, Thompson AJ, Bowen DG, Strasser SI, Koorey D, Sharland AF, Yang JY, McCaughan GW, Shackel NA.

Transplantation. 2015 Sep;99(9):e120-6. doi: 10.1097/TP.0000000000000617.

PMID:
25706280
5.

An extensive antigenic footprint underpins immunodominant TCR adaptability against a hypervariable viral determinant.

Nivarthi UK, Gras S, Kjer-Nielsen L, Berry R, Lucet IS, Miles JJ, Tracy SL, Purcell AW, Bowden DS, Hellard M, Rossjohn J, McCluskey J, Bharadwaj M.

J Immunol. 2014 Dec 1;193(11):5402-13. doi: 10.4049/jimmunol.1401357. Epub 2014 Oct 29.

6.

A novel hepatitis B virus S gene insertion associated with reduced humoral immunity and diagnostic escape.

Flanagan E, Thompson AJ, Colledge D, Edwards R, Littlejohn M, Walsh R, Warner N, Bowden DS, Iser DM.

Intern Med J. 2014 Jul;44(7):709-10. doi: 10.1111/imj.12465. No abstract available.

PMID:
25041776
7.

ITPA genotype protects against anemia during peginterferon and ribavirin therapy but does not influence virological response.

Holmes JA, Roberts SK, Ali RJ, Dore GJ, Sievert W, McCaughan GW, Crawford DH, Cheng WS, Weltman MD, Bonanzinga S, Visvanathan K, Sundararajan V, Desmond PV, Bowden DS, Matthews GV, Thompson AJ; CHARIOT Study Group.

Hepatology. 2014 Jun;59(6):2152-60. doi: 10.1002/hep.27022. Epub 2014 Apr 25.

PMID:
24449403
8.

Short duration of lamivudine for the prevention of hepatitis B virus transmission in pregnancy: lack of potency and selection of resistance mutations.

Ayres A, Yuen L, Jackson KM, Manoharan S, Glass A, Maley M, Yoo W, Hong SP, Kim SO, Luciani F, Bowden DS, Bayliss J, Levy MT, Locarnini SA.

J Viral Hepat. 2014 Nov;21(11):809-17. doi: 10.1111/jvh.12212. Epub 2013 Dec 11.

PMID:
24329944
9.

Molecular epidemiology of hepatitis B in the Indigenous people of northern Australia.

Davies J, Littlejohn M, Locarnini SA, Whiting S, Hajkowicz K, Cowie BC, Bowden DS, Tong SY, Davis JS.

J Gastroenterol Hepatol. 2013 Jul;28(7):1234-41. doi: 10.1111/jgh.12177.

PMID:
23432545
10.

IL28B genotype is not useful for predicting treatment outcome in Asian chronic hepatitis B patients treated with pegylated interferon-α.

Holmes JA, Nguyen T, Ratnam D, Heerasing NM, Tehan JV, Bonanzinga S, Dev A, Bell S, Pianko S, Chen R, Visvanathan K, Hammond R, Iser D, Rusli F, Sievert W, Desmond PV, Bowden DS, Thompson AJ.

J Gastroenterol Hepatol. 2013 May;28(5):861-6. doi: 10.1111/jgh.12110.

PMID:
23301835
11.

A multistate outbreak of hepatitis A associated with semidried tomatoes in Australia, 2009.

Donnan EJ, Fielding JE, Gregory JE, Lalor K, Rowe S, Goldsmith P, Antoniou M, Fullerton KE, Knope K, Copland JG, Bowden DS, Tracy SL, Hogg GG, Tan A, Adamopoulos J, Gaston J, Vally H.

Clin Infect Dis. 2012 Mar;54(6):775-81. doi: 10.1093/cid/cir949. Epub 2012 Jan 11.

PMID:
22238166
12.

Antigen-driven patterns of TCR bias are shared across diverse outcomes of human hepatitis C virus infection.

Miles JJ, Thammanichanond D, Moneer S, Nivarthi UK, Kjer-Nielsen L, Tracy SL, Aitken CK, Brennan RM, Zeng W, Marquart L, Jackson D, Burrows SR, Bowden DS, Torresi J, Hellard M, Rossjohn J, McCluskey J, Bharadwaj M.

J Immunol. 2011 Jan 15;186(2):901-12. doi: 10.4049/jimmunol.1003167. Epub 2010 Dec 15.

13.

Hepatic TLR2 & TLR4 expression correlates with hepatic inflammation and TNF-α in HCV & HCV/HIV infection.

Berzsenyi MD, Roberts SK, Preiss S, Woollard DJ, Beard MR, Skinner NA, Bowden DS, Visvanathan K.

J Viral Hepat. 2011 Dec;18(12):852-60. doi: 10.1111/j.1365-2893.2010.01390.x. Epub 2010 Nov 3.

PMID:
21050341
14.

GB virus C genotype 2 predominance in a hepatitis C virus/HIV infected population associated with reduced liver disease.

Berzsenyi MD, Bowden DS, Roberts SK, Revill PA.

J Gastroenterol Hepatol. 2009 Aug;24(8):1407-10. doi: 10.1111/j.1440-1746.2009.05920.x.

PMID:
19702909
15.

High incidence of hepatitis C virus reinfection in a cohort of injecting drug users.

Aitken CK, Lewis J, Tracy SL, Spelman T, Bowden DS, Bharadwaj M, Drummer H, Hellard M.

Hepatology. 2008 Dec;48(6):1746-52. doi: 10.1002/hep.22534.

PMID:
18844233
16.

New developments in HBV molecular diagnostics and quantitative serology.

Bowden DS, Thompson AJ.

Hepatol Int. 2008 May;2(Supplement 1):3-11. doi: 10.1007/s12072-008-9051-8. Epub 2008 Feb 13.

17.

Consecutive infections and clearances of different hepatitis C virus genotypes in an injecting drug user.

Aitken CK, Tracy SL, Revill P, Bharadwaj M, Bowden DS, Winter RJ, Hellard ME.

J Clin Virol. 2008 Apr;41(4):293-6. doi: 10.1016/j.jcv.2007.12.007. Epub 2008 Feb 1.

PMID:
18242125
18.

Reduction in hepatitis C-related liver disease associated with GB virus C in human immunodeficiency virus coinfection.

Berzsenyi MD, Bowden DS, Kelly HA, Watson KM, Mijch AM, Hammond RA, Crowe SM, Roberts SK.

Gastroenterology. 2007 Dec;133(6):1821-30. Epub 2007 Sep 5.

PMID:
18054555
19.

Chronic hepatitis C virus infection: genotyping and its clinical role.

Bowden DS, Berzsenyi MD.

Future Microbiol. 2006 Jun;1(1):103-12. Review.

PMID:
17661689
20.

Lamivudine resistance in patients with chronic hepatitis B: role of clinical and virological factors.

Thompson AJ, Ayres A, Yuen L, Bartholomeusz A, Bowden DS, Iser DM, Chen RY, Demediuk B, Shaw G, Bell SJ, Watson KJ, Locarnini SA, Desmond PV.

J Gastroenterol Hepatol. 2007 Jul;22(7):1078-85.

PMID:
17608854
21.

Effects of Silybum marianum on serum hepatitis C virus RNA, alanine aminotransferase levels and well-being in patients with chronic hepatitis C.

Gordon A, Hobbs DA, Bowden DS, Bailey MJ, Mitchell J, Francis AJ, Roberts SK.

J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 2):275-80.

PMID:
16460486
22.

GB virus C: insights into co-infection.

Berzsenyi MD, Bowden DS, Roberts SK.

J Clin Virol. 2005 Aug;33(4):257-66. Review.

PMID:
15922655
23.

Male to male sex is associated with a high prevalence of exposure to GB virus C.

Berzsenyi MD, Bowden DS, Bailey MJ, White C, Coghlan P, Dudley FJ, Roberts SK.

J Clin Virol. 2005 Jul;33(3):243-6.

PMID:
15911447
24.

Molecular epidemiology of hepatitis C virus in a social network of injection drug users.

Aitken CK, McCaw RF, Bowden DS, Tracy SL, Kelsall JG, Higgs PG, Kerger MJ, Nguyen H, Crofts JN.

J Infect Dis. 2004 Nov 1;190(9):1586-95. Epub 2004 Sep 23.

PMID:
15478062
25.

Validation of assembled nucleic acid-based tests in diagnostic microbiology laboratories.

Dimech W, Bowden DS, Brestovac B, Byron K, James G, Jardine D, Sloots T, Dax EM.

Pathology. 2004 Feb;36(1):45-50. Review.

PMID:
14757556
26.

Evidence of patient-to-patient transmission of hepatitis C virus through contaminated intravenous anaesthetic ampoules.

Tallis GF, Ryan GM, Lambert SB, Bowden DS, McCaw R, Birch CJ, Moloney M, Carnie JA, Locarnini SA, Rouch GJ, Catton MG.

J Viral Hepat. 2003 May;10(3):234-9.

PMID:
12753344
27.

Prevalence of Hepatitis g/GBV-C in a Healthy Paediatric Population.

Siebert DJ, Bowden DS, Tracy SL, Hardikar W.

J Paediatr Child Health. 2002 Aug;38(4):423. No abstract available.

PMID:
12174012
28.

Serum alanine aminotransferase levels and the detection of hepatitis C virus (HCV) in chronic HCV infections.

Kelly HA, Maskill WJ, Sievert W, Bowden DS.

Med J Aust. 2002 Feb 4;176(3):139. No abstract available.

PMID:
11936320
29.

Rubella virus replication and links to teratogenicity.

Lee JY, Bowden DS.

Clin Microbiol Rev. 2000 Oct;13(4):571-87. Review.

30.

Molecular analysis of human immunodeficiency virus strains associated with a case of criminal transmission of the virus.

Birch CJ, McCaw RF, Bulach DM, Revill PA, Carter JT, Tomnay J, Hatch B, Middleton TV, Chibo D, Catton MG, Pankhurst JL, Breschkin AM, Locarnini SA, Bowden DS.

J Infect Dis. 2000 Sep;182(3):941-4. Epub 2000 Aug 17.

PMID:
10950794
31.

Combined infection of Norwalk-like virus and verotoxin-producing bacteria associated with a gastroenteritis outbreak.

Bettelheim KA, Bowden DS, Doultree JC, Catton MG, Chibo D, Ryan NJ, Wright PJ, Gunesekere IC, Griffith JM, Lightfoot D, Hogg GG, Bennett-Wood V, Marshall JA.

J Diarrhoeal Dis Res. 1999 Mar;17(1):34-6.

PMID:
10892495
32.

Hepatitis G: viroprevalence and seroconversion in a high-risk group of children.

Hardikar W, Moaven LD, Bowden DS, Locarnini SA, Smith AL.

J Viral Hepat. 1999 Jul;6(4):337-41.

PMID:
10607249
33.

Localization of rubella virus core particles in vero cells.

Lee JY, Marshall JA, Bowden DS.

Virology. 1999 Dec 5;265(1):110-9.

34.

Inactivation of feline calicivirus, a Norwalk virus surrogate.

Doultree JC, Druce JD, Birch CJ, Bowden DS, Marshall JA.

J Hosp Infect. 1999 Jan;41(1):51-7.

PMID:
9949965
35.

Rubella virus replication complexes are virus-modified lysosomes.

Magliano D, Marshall JA, Bowden DS, Vardaxis N, Meanger J, Lee JY.

Virology. 1998 Jan 5;240(1):57-63.

36.

Hepatitis G virus and fulminant hepatic failure: evidence for transfusion-related infection.

Moaven LD, Locarnini SA, Bowden DS, Kim JP, Breschkin A, McCaw R, Yun A, Wages J Jr, Jones B, Angus P.

J Hepatol. 1997 Oct;27(4):613-9.

PMID:
9365036
37.

Hepatitis C virus genotypes in Australia.

McCaw R, Moaven L, Locarnini SA, Bowden DS.

J Viral Hepat. 1997 Sep;4(5):351-7.

PMID:
9310934
38.

Prevalence of hepatitis G virus antibodies in Queensland blood donors.

Moaven LD, Young IF, Bowden DS, Locarnini SA.

Med J Aust. 1997 May 5;166(9):507, 509. No abstract available.

PMID:
9152349
39.

Chronic hepatitis C: effect of alcohol on hepatitic activity and viral titre.

Cromie SL, Jenkins PJ, Bowden DS, Dudley FJ.

J Hepatol. 1996 Dec;25(6):821-6.

PMID:
9007708
40.

Mutations in the hepatitis B virus precore/core gene and core promoter in patients with severe recurrent disease following liver transplantation.

McMillan JS, Bowden DS, Angus PW, McCaughan GW, Locarnini SA.

Hepatology. 1996 Dec;24(6):1371-8.

PMID:
8938164
41.

Prevalence of hepatitis G virus in Queensland blood donors.

Moaven LD, Hyland CA, Young IF, Bowden DS, McCaw R, Mison L, Locarnini SA.

Med J Aust. 1996 Oct 7;165(7):369-71.

PMID:
8890843
42.

The changing prevalence of hepatitis C virus types in injecting drug users between 1971 and 1994.

Moaven LD, Crofts N, McCaw R, Bowden DS.

Med J Aust. 1996 Aug 19;165(4):233. No abstract available.

PMID:
8773656
43.

Mother-to-baby transmission of hepatitis G virus.

Moaven LD, Tennakoon PS, Bowden DS, Locarnini SA.

Med J Aust. 1996 Jul 15;165(2):84-5.

PMID:
8692068
44.

Chronic hepatitis C and interferon alfa therapy: predictors of long term response.

Jenkins PJ, Cromie SL, Bowden DS, Finch CF, Dudley FJ.

Med J Aust. 1996 Feb 5;164(3):150-2.

PMID:
8628133
45.

New hepatitis viruses: are there enough letters in the alphabet?

Bowden DS, Moaven LD, Locarnini SA.

Med J Aust. 1996 Jan 15;164(2):87-9. Review.

PMID:
8569579
46.

Membrane junctions associated with rubella virus infected cells.

Lee JY, Bowden DS, Marshall JA.

J Submicrosc Cytol Pathol. 1996 Jan;28(1):101-8.

PMID:
8929632
47.
48.

Breastfeeding and the risk of vertical transmission of hepatitis C virus.

Grayson ML, Braniff KM, Bowden DS, Turnidge JD.

Med J Aust. 1995 Jul 17;163(2):107. No abstract available.

PMID:
7616888
49.

Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation.

Angus PW, Locarnini SA, McCaughan GW, Jones RM, McMillan JS, Bowden DS.

Hepatology. 1995 Jan;21(1):14-8.

PMID:
7806147
50.

Blood-borne virus infections among Australian injecting drug users: implications for spread of HIV.

Crofts N, Hopper JL, Milner R, Breschkin AM, Bowden DS, Locarnini SA.

Eur J Epidemiol. 1994 Dec;10(6):687-94.

PMID:
7672048

Supplemental Content

Loading ...
Support Center